World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
65
Citations
14914
World Ranking
2508
National Ranking
25

Juhani Eskola publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Juhani Eskola sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 157 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Juhani Eskola D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Juhani Eskola sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Juhani Eskola is affiliated with the Finnish Institute for Health and Welfare (THL) in Finland. Their research primarily spans the fields of medicine, economics, econometrics and finance, and social sciences, with a focus on public health and related economic evaluations.

Their work addresses multiple subfields including economics and econometrics, health, epidemiology, general health professions, and infectious diseases. The main topics covered by Eskola's research include vaccine coverage and hesitancy, health systems, economic evaluations, quality of life, pharmaceutical economics and policy, child and adolescent health, pneumonia and respiratory infections, respiratory viral infections research, and SARS-CoV-2 and COVID-19 research.

Eskola has published research in various peer-reviewed journals. Frequent publication venues include:

  • Value in Health
  • Expert Review of Vaccines
  • Vaccine

Recent papers authored or co-authored by Eskola illustrate a consistent focus on vaccines and immunisation programmes. These include:

  • "Guiding Principles for Evaluating Vaccines in Joint Health Technology Assessment in the European Union: Preparing for the European Union's Regulation on Health Technology Assessment for Vaccines," 2024, Value in Health
  • "Assessment of the comprehensiveness of paediatric national immunisation programmes in Europe: expert validation and future perspectives," 2024, Expert Review of Vaccines
  • "Considerations for unblinding individual study participants during vaccine trials," 2023, Vaccine

Frequent co-authors collaborating with Eskola highlight ongoing partnerships within the vaccine research community. These collaborators include:

  • Ugne Sabale
  • Nathalie Largeron
  • Paolo D'Agostino
  • Ruth Chapman
  • Dávid Dankó

The research outputs indicate a blend of clinical and economic perspectives on vaccines and immunisation policies, particularly with respect to evaluation frameworks and national health programmes. The work on vaccine hesitancy and coverage further reflects an interest in public acceptance and implementation aspects of vaccination strategies.

Eskola's contribution to economic evaluations, quality of life metrics, and pharmaceutical policy situates their research at the intersection of health outcomes and economic impact, supporting policy-relevant discourse in health technology assessment and immunisation practices across Europe.

Best Publications

  • Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

    Eskola J;Kilpi T;Palmu A;Jokinen J

  • Addressing the vaccine confidence gap

    Heidi J Larson;Louis Z Cooper;Juhani Eskola;Samuel L Katz

  • Global epidemiology of invasive meningococcal disease.

    Rabab Z Jafri;Asad Ali;Nancy E Messonnier;Carol Tevi-Benissan

  • A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.

    J Eskola;H Käyhty;A K Takala;H Peltola

  • Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine.

    Unknown

  • Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants

    Ron Dagan;Juhani Eskola;Claude Leclerc;Odile Leroy

  • Epidemiology of invasive pneumococcal infections in children in Finland.

    Juhani Eskola;Aino K. Takala;Eija Kela;Eeva Pekkanen

  • Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.

    J Eskola;H Peltola;A K Takala;H Käyhty

  • Pneumococcal conjugate vaccines.

    Juhani Eskola;Merja Anttila

  • Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.

    Terhi Kilpi;Heidi Åhman;Jukka Jokinen;Kari S. Lankinen

  • Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

    Steven Black;Juhani Eskola;Claire Anne Siegrist;Neal Halsey

  • Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis

    Juhani Eskola;Joel Ward;Ron Dagan;David Goldblatt

  • Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

    Helena Käyhty;Heidi Åhman;Pirjo-Riitta Rönnberg;Risto Tillikainen

  • Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine

    Juhani Eskola;Rose-Marie Ölander;Tapani Hovi;Leila Litmanen

  • Avidity of IgG for Streptococcus pneumoniae Type 6B and 23F Polysaccharides in Infants Primed with Pneumococcal Conjugates and Boosted with Polysaccharide or Conjugate Vaccines

    Merja Anttila;Juhani Eskola;Heidi Åhman;Helena Käyhty

  • Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.

    Heidi Åhman;Helena Käyhty;Pirjo Tamminen;Arja Vuorela

  • Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory.

    Heidi Åhman;Helena Käyhty;Hannele Lehtonen;Odile Leroy

  • How to deal with vaccine hesitancy

    Juhani Eskola;Philippe Duclos;Melanie Schuster;Noni E MacDonald

  • The causes of hospital-treated acute lower respiratory tract infection in children.

    Hanna Nohynek;Juhani Eskola;Eija Laine;Pekka Halonen

  • Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children.

    Nohynek H;Valkeila E;Leinonen M;Eskola J

  • Risk factors of invasive Haemophilus influenzae type b disease among children in Finland

    Aino K. Takala;Juhani Eskola;Juni Palmgren;Pirjo-Riitta Rönnberg

Frequent Co-Authors

Helena Käyhty
Helena Käyhty Finnish Institute for Health and Welfare (THL)
Heikki Peltola
Heikki Peltola University of Helsinki
Maija Leinonen
Maija Leinonen Finnish Institute for Health and Welfare (THL)
P. Helena Mäkelä
P. Helena Mäkelä University of Helsinki
Ron Dagan
Ron Dagan Ben-Gurion University of the Negev
Tapani Hovi
Tapani Hovi National Institutes of Health
Keith P. Klugman
Keith P. Klugman Bill & Melinda Gates Foundation
Claire-Anne Siegrist
Claire-Anne Siegrist University of Geneva
Steven Black
Steven Black Cincinnati Children's Hospital Medical Center
Erkki Savilahti
Erkki Savilahti University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various related fields that blend science with practical applications. For students interested in healthcare, exploring pathways like becoming a ccls certification professional can provide specialized roles supporting patient well-being. This certification can complement a microbiology background by focusing on emotional care in medical settings.

For those facing unique challenges, such as individuals seeking online degrees for felons, there are accessible programs that offer a fresh start and career growth. Microbiology-related courses may be part of these flexible degree options, emphasizing that past setbacks don’t necessarily limit future opportunities.

Another critical pathway is within nursing, where microbiology knowledge is valuable for specialized roles like a functional medicine nurse practitioner salary reflects the increasing demand for integrative care providers skilled in understanding disease mechanisms and patient treatment.

Additionally, careers in healthcare administration, such as becoming a certified professional coder (cpc), can also intersect with microbiology through medical billing and coding jobs in clinical laboratories and hospitals. These roles ensure that healthcare services are accurately documented and reimbursed, supporting laboratory operations indirectly.

Best Scientists Citing Juhani Eskola

Trending Scientists

Recently Published Articles